Literature DB >> 1390036

Natural history of varicella zoster virus.

S K Tyring1.   

Abstract

The varicella zoster virus (VZV) is a herpesvirus responsible for two distinct clinical disorders, primary varicella (chickenpox) and zoster (shingles). Primary varicella is a common childhood disease in Western countries, which presents as pruritic macules, papules, vesicles, pustules, and crusts, usually on the back, chest, face, and abdomen. In immunocompetent children, chickenpox is generally a mild disease with little morbidity and rare mortality. Primary varicella is associated with more morbidity in adults. Following resolution of primary varicella, VZV persists in a latent form in dorsal ganglion cells for what is usually an extended period of time. For reasons that are still poorly understood, VZV can later start replicating in the ganglion, producing severe neuralgia and spread of the virus down the sensory nerve. Vesicles then appear on the skin in the distribution of this nerve, producing the characteristic dermatomal rash of shingles. The vesicles progress to pustules, then to crusts that eventually are lost. Scarring and changes in pigmentation can result, but the most frequent sequela of zoster is postherpetic neuralgia, which is usually most severe in the elderly. Primary varicella or herpes zoster in immunocompromised patients can sometimes involve internal organs (eg, lungs, liver, brain) resulting in high rates of morbidity and mortality. Congenital VZV infection is uncommon but can result in severe congenital malformations. A Tzanck smear can be useful to demonstrate a herpesvirus infection, but confirmation of VZV as the cause of the infection requires at least one of the following tests: culture, serology, direct immunofluorescence staining, or molecular techniques.

Entities:  

Mesh:

Year:  1992        PMID: 1390036

Source DB:  PubMed          Journal:  Semin Dermatol        ISSN: 0278-145X


  7 in total

1.  Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination.

Authors:  Peter Norberg; Jan-Ake Liljeqvist; Tomas Bergström; Scott Sammons; D Scott Schmid; Vladimir N Loparev
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Herpes zoster mistaken for biliary colic and treated by laparoscopic cholecystectomy: a cautionary case report.

Authors:  I Hassan; J H Donohue
Journal:  Surg Endosc       Date:  1996-08       Impact factor: 4.584

Review 3.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

Review 4.  Antiviral therapy of acute herpes zoster in older patients.

Authors:  K Herne; R Cirelli; P Lee; S K Tyring
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

5.  A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax.

Authors:  Larry I Gilderman; James F Lawless; Thomas M Nolen; Tina Sterling; Ruth Z Rutledge; Doreen A Fernsler; Neal Azrolan; Santosh C Sutradhar; William W Wang; Ivan S F Chan; Katia Schlienger; Florian Schödel; Jeffrey L Silber
Journal:  Clin Vaccine Immunol       Date:  2007-12-12

6.  Real-world database investigating the association between diabetes mellitus and herpes zoster in Taiwan.

Authors:  Shih-Wei Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Chemical reconstruction of skin scars therapy using 100% trichloroacetic Acid in the treatment of atrophic facial post varicella scars: a pilot study.

Authors:  Nidheesh Agarwal; Asit Mittal; Cm Kuldeep; Lalit Kumar Gupta; Ashok Kumar Khare; Sharad Mehta
Journal:  J Cutan Aesthet Surg       Date:  2013-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.